APLM
Price
$19.50
Change
+$1.07 (+5.81%)
Updated
Oct 15 closing price
Capitalization
41.8M
Intraday Buy/Sell Signals
IPHA
Price
$2.11
Change
+$0.08 (+3.94%)
Updated
Oct 15 closing price
Capitalization
193.16M
28 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

APLM vs IPHA

Header iconAPLM vs IPHA Comparison
Open Charts APLM vs IPHABanner chart's image
Apollomics
Price$19.50
Change+$1.07 (+5.81%)
Volume$534.56K
Capitalization41.8M
Innate Pharma SA
Price$2.11
Change+$0.08 (+3.94%)
Volume$15.01K
Capitalization193.16M
APLM vs IPHA Comparison Chart in %
APLM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLM vs. IPHA commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and IPHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (APLM: $19.50 vs. IPHA: $2.11)
Brand notoriety: APLM and IPHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 159% vs. IPHA: 107%
Market capitalization -- APLM: $41.8M vs. IPHA: $193.16M
APLM [@Biotechnology] is valued at $41.8M. IPHA’s [@Biotechnology] market capitalization is $193.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whileIPHA’s FA Score has 1 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • IPHA’s FA Score: 1 green, 4 red.
According to our system of comparison, APLM is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 5 TA indicator(s) are bullish while IPHA’s TA Score has 6 bullish TA indicator(s).

  • APLM’s TA Score: 5 bullish, 4 bearish.
  • IPHA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IPHA is a better buy in the short-term than APLM.

Price Growth

APLM (@Biotechnology) experienced а +5.79% price change this week, while IPHA (@Biotechnology) price change was +5.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +18.20%, and the average quarterly price growth was +82.76%.

Reported Earning Dates

IPHA is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHA($193M) has a higher market cap than APLM($41.8M). APLM YTD gains are higher at: 100.000 vs. IPHA (14.674).
APLMIPHAAPLM / IPHA
Capitalization41.8M193M22%
EBITDA-56.38MN/A-
Gain YTD100.00014.674681%
P/E RatioN/AN/A-
Revenue0N/A-
Total CashN/AN/A-
Total Debt4.72MN/A-
FUNDAMENTALS RATINGS
IPHA: Fundamental Ratings
IPHA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
32
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLMIPHA
RSI
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
47%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
42%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 29 days ago
75%
Bullish Trend 1 day ago
73%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
30%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWINF0.96N/A
N/A
Naked Wines PLC
SUCEF26.93N/A
N/A
Sumitomo Osaka Cement Co., Ltd.
DCNSF7.64N/A
N/A
Dai-ichi Life Holdings, Inc.
WYGPF9.39N/A
N/A
Worley Ltd.
KNRLF0.10-0.01
-6.45%
Kontrol Technologies Corp.

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
+5.79%
SNTI - APLM
47%
Loosely correlated
+11.06%
HCWB - APLM
45%
Loosely correlated
-2.44%
MGX - APLM
37%
Loosely correlated
+7.93%
IPHA - APLM
36%
Loosely correlated
+3.94%
QSI - APLM
34%
Loosely correlated
+22.33%
More

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
+3.94%
MDGL - IPHA
43%
Loosely correlated
-0.84%
APLM - IPHA
36%
Loosely correlated
+5.79%
SLNO - IPHA
34%
Loosely correlated
+6.48%
VALN - IPHA
30%
Poorly correlated
+0.86%
TNXP - IPHA
30%
Poorly correlated
-2.42%
More